Literature DB >> 11067953

Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion.

C L Kepley1, L Youssef, R P Andrews, B S Wilson, J M Oliver.   

Abstract

Human basophils respond to Ag-induced cross-linking of their high affinity IgE receptor, FcepsilonRI, by releasing histamine and other mediators from granules, producing IL-4 and other cytokines and, as shown in this study, by forming membrane ruffles and showing increased very late Ag-4 (VLA-4)-mediated adhesion to VCAM-1-expressing target cells. We have identified five blood donors whose basophils lack detectable levels of the FcepsilonRI-associated protein tyrosine kinase, Syk. Despite showing no obvious ultrastructural differences from normal basophils, nonreleaser basophils fail to form membrane ruffles, to show increased VLA-4-mediated adhesive activity, or to produce IL-4 in response to FcepsilonRI cross-linking. Although Syk protein levels are suppressed in basophils from all five donors, Syk mRNA is consistently present. Furthermore, culturing nonreleaser basophils for 4 days with IL-3 restores Syk protein expression and FcepsilonRI-mediated histamine release. Understanding the reversible suppression of Syk protein expression in nonreleaser basophils, and learning to replicate this property in patients with allergic inflammation could be a powerful and specific way to limit symptomatic disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067953     DOI: 10.4049/jimmunol.165.10.5913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  In vitro desensitization of human skin mast cells.

Authors:  Wei Zhao; Gregorio Gomez; Matthew Macey; Christopher L Kepley; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  Syk deficiency in human non-releaser lung mast cells.

Authors:  Gregorio Gomez; Lawrence Schwartz; Christopher Kepley
Journal:  Clin Immunol       Date:  2007-08-10       Impact factor: 3.969

3.  Diagnostic value of the basophil activation test in evaluating Hymenoptera venom sensitization.

Authors:  Andreja Peternelj; Mira Silar; Nissera Bajrovic; Katja Adamic; Ema Music; Mitja Kosnik; Peter Korosec
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 4.  New approaches to allergen immunotherapy.

Authors:  Christopher L Kepley
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 5.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Authors:  Peter Valent; Cem Akin; Patrizia Bonadonna; Karin Hartmann; Knut Brockow; Marek Niedoszytko; Boguslaw Nedoszytko; Frank Siebenhaar; Wolfgang R Sperr; Joanna N G Oude Elberink; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Andreas Reiter; Hanneke C Kluin-Nelemans; Olivier Hermine; Jason Gotlib; Sigurd Broesby-Olsen; Alberto Orfao; Hans-Peter Horny; Massimo Triggiani; Michel Arock; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-05

6.  Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.

Authors:  Asifa K Zaidi; Sarbjit S Saini; Donald W Macglashan
Journal:  J Allergy Clin Immunol       Date:  2010-03-17       Impact factor: 10.793

7.  Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study.

Authors:  Sangita P Patil; Julie Wang; Ying Song; Sally Noone; Nan Yang; Sylvan Wallenstein; Hugh A Sampson; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2011-07-26       Impact factor: 10.793

8.  Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Authors:  Susan S Ishmael; Donald W MacGlashan
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

9.  Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.

Authors:  Janet M Oliver; Christy A Tarleton; Laura Gilmartin; Tereassa Archibeque; Clifford R Qualls; Lorena Diehl; Bridget S Wilson; Mark Schuyler
Journal:  Int Arch Allergy Immunol       Date:  2009-10-22       Impact factor: 2.749

10.  Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2.

Authors:  Sarbjit S Saini; Miya Paterniti; Kavitha Vasagar; Scott P Gibbons; Patricia M Sterba; Becky M Vonakis
Journal:  Clin Immunol       Date:  2009-05-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.